Improved survival with surgery in prostate cancer patients without medical comorbidity: A self-fulfilling prophecy?

European Urology

Volumn 64, Issue 3, 2013, Pages 381-383

  Zumsteg, Zachary S ^a   Zelefsky, Michael J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BODY MASS; BRACHYTHERAPY; CANCER CONTROL; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHARLSON COMORBIDITY INDEX; COMORBIDITY; EDITORIAL; FOLLOW UP; GLEASON SCORE; HODGKIN DISEASE; HUMAN; HYPERCHOLESTEROLEMIA; LIFE EXPECTANCY; METASTASIS; PATIENT PREFERENCE; PELVIS LYMPH NODE; PHYSICIAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; RADIATION DOSE; SEMINOMA; SMOKING; SOCIAL STATUS; SYSTEMATIC REVIEW (TOPIC);

BRACHYTHERAPY; HUMANS; MALE; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 84881158783     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2013.05.037     Document Type: Editorial

References (10)

1. T.J. Wilt, R. MacDonald, I. Rutks, T.A. Shamliyan, B.C. Taylor, and R.L. Kane Systematic review: Comparative effectiveness and harms of treatments for clinically localized prostate cancer Ann Intern Med 148 2008 435 448
2. M.J. Schymura, A.R. Kahn, and R.R. German Factors associated with initial treatment and survival for clinically localized prostate cancer: Results from the CDC-NPCR Patterns of Care Study (PoC1) BMC Cancer 10 2010 152
3. K.G. Nepple, A.J. Stephenson, and D. Kallogjeri Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity Eur Urol 64 2013 372 378
4. P. Warde, M. Mason, and K. Ding Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: A randomised, phase 3 trial Lancet 378 2011 2104 2111
5. A. Widmark, O. Klepp, and A. Solberg Endocrine treatment, with or without RT, in locally advanced prostate cancer (SPCG-7/SFUO-3): An open randomised phase III trial Lancet 373 2009 301 308
6. M. Bolla, H. van Poppel, and B. Tombal Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: Long-term results of a randomised controlled trial (EORTC trial 22911) Lancet 380 2012 2018 2027
7. M.J. Zelefsky, X. Pei, and T. Teslova Secondary cancers after intensity-modulated radiotherapy, brachytherapy and radical prostatectomy for the treatment of prostate cancer: Incidence and cause-specific survival outcomes according to the initial treatment intervention BJU Int 110 2012 1696 1701
8. P.L. Nguyen, Y. Je, and F.A. Schutz Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: A meta-analysis of randomized trials JAMA 306 2011 2359 2366
9. P.M. Pierorazio, P.C. Walsh, A.W. Partin, and J.I. Epstein Prognostic Gleason grade grouping: Data based on the modified Gleason scoring system BJU Int 111 2013 753 760
10. J.M. Crook, A. Gomez-Iturriaga, and K. Wallace Comparison of health-related quality of life 5 years after SPIRIT: Surgical Prostatectomy Versus Interstitial Radiation Intervention Trial J Clin Oncol 29 2011 362 368